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ABSTRACT

Lead poisoning is a perennial and serious health problem around the world. The
daily widespread use of lead has dramatically increased the degree and longevity of its
exposure to humans, exacerbating the task of lead poisoning treatment. Lead exerts
adverse effects on cardiovascular, central nervous, renal, gastrointestinal, and
reproductive systems.
The common treatment for lead poisoning is chelation therapy. Chelators were
proposed to treat lead poisoning a very long time ago. However, chelators have severe
side effects that could cause more problems, in addition to lead poisoning. Therefore,
another group of drugs has been suggested --- antioxidants. This type of chemicals not
only possesses the chelating abilities for lead cation, but also has only small side effects
on tissues. In addition, antioxidants are able to reduce the oxidative stress induced by
lead so that a normal antioxidant defense system can be maintained in the human body.
Vitamin C, Vitamin E, α-lipoic acid, β-carotene, and N-acetylcysteine are the common
antioxidants used for treating lead poisoning. In recent years, a new chemical, Nacetylcysteine amide, the amide form of NAC, has been synthesized and tested as a
promising new drug to treat oxidative stress related disorders.
This research has focused on comparing the chelating abilities that Nacetylcysteine (NAC) and N-acetylcysteine amide (NACA) have for lead divalent cation.
The complex forms of Pb-NAC and Pb-NACA were determined, followed by estimating
the amount of lead chelated by these antioxidants. The results showed that there were
multiple complex forms for both Pb-NAC and Pb-NACA, and that NACA has a higher
affinity for lead than NAC.
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1. INTRODUCTION

Lead poisoning is a serious health problem world-wide. Lead and lead chemicals
have been commonly used for multiple purposes in different areas over thousands of
years. Lead exposure emanates from sources such as paints (Mathee et al., 2007; Gould,
2009), drinking water (Patrick, 2006), food, gasoline (Patrick, 2006), occupational
hazards (Shobha et al., 2009), and etc. The widespread use of lead has resulted in lead
poisoning becoming a very important toxicity issue. According to a statement issued by
the Centers for Disease Control (CDC) in 1985, blood lead levels above 10 μg/dl would
be a concern for human health. Children may develop problems in IQ, hearing, and
overall developmental growth whereas adults could develop hypertension (Gurer et al.,
2000). With elevated blood lead levels ranging from 20 μg/dl to 50 μg / dl, an individual
is likely to suffer from abnormal metabolism and cessation of the heme synthesis (Fonte
et al., 2007). With much higher blood lead levels (above 50 μg / dl), neuropathy (Catton
et al., 1970), encephalopathy (Karri et al., 2008), and even death would result (Figure
1.1).
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Figure 1.1. The adverse effects of lead poisoning on human health.
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2. BACKGROUND

2.1. MECHANISM
Lead poisoning continues to be a health threatening problem. Lead substances can
affect human health by inhalation (Landrigan and Todd, 1994), ingestion (Handley et al.,
2007) and dermal contact. Lead is toxic to various organs and tissues, and will induce
failure of certain enzyme functions and physiological processes in the body, such as the
inhibition of heme synthesis (Zhao et al,. 2007), protein oxidation (Sandhir et al., 1994),
and lipid peroxidation (Ribarow et al., 1981). A complete understanding of mechanisms
governing these processes has not been achieved. However, there are several theories
explaining the toxicity of lead.
One mechanism proposed is that lead is able to oxidize glutathione (GSH) (Kidd,
1997), resulting in an imbalance of the antioxidant defense system, and thereby inducing
the generation of free radicals. Lead divalent cation has a strong binding capacity for
sulfhydryl group-containing proteins and enzymes, and therefore would react with a thiol
group containing proteins or enzymes to produce free radicals which would decrease
GSH levels (Patrick, 2006), resulting in a decline in the GSH/GSSG ratio (Figure 2.1.). In
this scenario, GSH is no longer a natural antioxidant that functions as scavenging reactive
oxygen species (ROS), detoxifying carcinogens, and regulating metabolism and the
immune system. Rather, the level of free radicals, such as hydrogen peroxide, hydroxyl
radical, and lipid peroxide, will be significantly increased in response to the presence of
Pb (II), resulting in oxidative stress (Gurer and Ercal, 2000).
Another adverse effect is the failure of heme synthesis (Flora, 2008). Lead
divalent cations are able to react with δ-aminolevulinic acid dehydratase (ALAD)
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(Mitchell et al., 1977) and ferrochelatase. ALAD, a cytosolic sulfhydryl enzyme, will
stop the conversion of two molecules of δ-aminolevulinic acid into porphobilinogen.
Therefore, heme biosynthesis in the cell would be terminated at ALAD. Ferrochelatase,
an enzyme in the last step of heme synthesis that occurs in the mitochondria, would have
much less activity in the presence of lead ions. As a result, these two important enzymes
in the heme synthesis would be greatly affected by lead, not being able to perform their
normal functions (Figure 2.1). This abnormal process would, in turn, stimulate δaminolevulinic acid synthetase. Thus, there would be an increased accumulation of ALA
and a decreased formation of porphobilinogen.
Accumulated ALA would induce ROS generation (Ryter, 2000). First, ALA
molecules would be converted into the ALA enol form by tautomerization. Secondly,
autoxidation of ALA enol generates an ALA• radical and a superoxide anion radical (O2˙

-

). ALA• would further oxidize into iminoALA and produce more superoxide anion
radical, forming hydrogen peroxide (H2O2) and oxygen. The iminoALA would then react
with H3O+, forming 2,4-dioxovaleric acid (DOVA) and ammonium ion. Then, the
autoxidation of ALA with oxyhemoglobin [Hb-Fe(II)] would produce met-hemoglobin
and H2O2. The final step is the generation of hydroxyl radicals (•OH) through the metal
catalyzed Haber-Weiss reaction (Equations 1-6).
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Figure 2.1. The effects of lead on heme synthesis and glutathione metabolism.
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2.2. TREATMENT
The major treatment for lead poisoning is chelation therapy (Porru and Alessio,
1996), aimed to remove accumulated lead in the body. The first chelators, used in treating
lead poisoning (Kety and Letonoff, 1941) were very effective in removing lead.
Ethylenediamine tetraacetic acid (EDTA), a famous and common drug in lead poisoning

treatment (Horowitz and Mirkin, 2001; Blanusa et al., 2005; Tzu et al., 2007), is capable
of decreasing lead levels in tissue. In the 1950s, CaNa2EDTA, a derivative of EDTA, was
first introduced for chelating Pb in acute lead poisoning (Flora et al., 1995). Later, British
Anti Lewisite (BAL), and Meso-2, 3-dimercaptosuccinic acid (DMSA) (Xiaojun Fang
and Quintus Fernando, 1993; Jie Zhang et al., 2004; Stangle et al., 2007) were also
developed for use in chelating therapies for lead poisoning.
However, these chelators have different adverse effects which are extremely
harmful. For instance, CaNa2EDTA itself is toxic for the renal system (Purser et al.,
1983), because it will induce cell necrosis. In addition, CaNa2EDTA is not able to travel
through cell membrane and, thus, cannot be used to eliminate lead in the cell. In addition,
chelators, such as CaNa2EDTA, are not capable of decreasing reactive oxygen species
(ROS) induced by lead, so the oxidative stress still exists in tissues even after chelation
therapy is applied. As a result, it is necessary to find other kinds of drugs to treat lead
poisoning. Antioxidants, such as Vitamin E and C, selenocystine (Sel) (Aykin-Burns et
al., 2006), N-acetylcysteine (NAC), N-acetylcysteine amide (NACA) (Aykin-Burns et
al., 2005; Penugonda et al., 2006), the amide form of NAC, and etc. were considered as
promising drugs to treat lead toxicity, because antioxidants not only decrease the blood
lead levels, but also help rebalance antioxidant defense systems.
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The ideal antioxidant for treating lead poisoning should be: 1) nontoxic; 2) able to
easily cross the cell membrane (in which case lead in the cell could be removed by
antioxidants as well as in extracellular fluids); and 3) have a strong affinity to the lead
divalent cation.
In previous studies, the abilities of decreasing the lead concentration in vivo
differed widely among various kinds of chelators and antioxidants. This study is aimed to
test and compare the chelating ability of two antioxidants --- NAC and NACA, in vitro.
The two molecules both have a thiol group, which makes possible the binding of Pb(II).
NAC has a carboxylic group with a negative charge, while NACA has an amide group on
the same site (Figure 2.2). The difference of this one functional group in the molecule
may contribute to their different affinities for Pb(II).

N-acetylcysteine

N-acetylcysteine amide

Figure 2.2. Molecular structures of N-acetylcysteine and N-acetylcysteine amide.

The stoichiometry of a Pb-antioxidant complex can be delineated using a UV/vis
spectrophotometer. Electrospray ionization mass spectrometry (ESI-MS) was adopted to
reveal the structure information of Pb-antioxidant complexes. The amount of lead that
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was complexed can be detected by using high performance liquid chromatography
(HPLC) and X-ray electron spectroscopy (XPS).

2.3. INSTRUMENTATION
2.3.1. Electrospray Ionization Mass Spectrometry (ESI-MS). Electrospray
ionization mass spectrometry is a useful analytical technique. By ionization, analytes of
interest can be detected by a mass spectrometer. ESI-MS is very useful to detect
macromolecules (Claudia Bich and Renato Zenobi, 2009) without any fragmentation.
2.3.1.1. Theory. Analytes will be first ionized after injection by a high voltage
needle, and have certain charges on them without fragmentation. Therefore, the mass – to
- charge (m/z) ratio of a molecule in the samples will be unique to others. With its
particular m/z ratio, an analyte could be detected by a mass spectrometer.
2.3.1.2. Procedure. Sample solutions will first be atomized using a high voltage
needle, during which the analytes become ions with certain charges, because there is a
strong electrical field during introduction. Then these ions will enter through a drying gas
phase and two pumping stages, at which the ions are separated in the mass analyzer by
different m/z ratios. With a mass spectrometer, the analytes could be detected
individually by their mass to charge ratio (Figure 2.3).
2.3.1.3. Electrospray and ionization. Analytes in samples will be introduced
into to the instrument by a capillary needle, which is applied with a very high voltage,
usually from 2 – 5 kV. Then there is a gradient electric – field for the generation of
analytes ionization before the drying gas phase. The voltage on the capillary needle could
be either positive or negative. However, the mechanism of the ionization process is not
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totally understood. It has been suggested that the production of ionic form analytes occurs
through two possible models: the ion evaporation model (IEM) and the charged residue
model (CRM). In the ion evaporation model, ions are released when the Coulombic
repulsion is large enough to overcome the liquid’s surface tension (Iribarne and
Thomson, 1976). In the charged residue model, solution droplets will have charges when
voltage is applied. When the Coulombic repulsion is equal to the surface tension of these
droplets, the excess of positive or negative charge in the droplets would be separated
from the solution, resulting in single ions (Taflin et al., 1989; Kebarle and Peschke,
1999) (Figure 2.4).

needle

gas phase

analyzer

Figure 2.3. Schematic of electrospray ionization spectroscopy.

By ionization, analytes of interest are added or removed by one proton, forming
positively charged analytes (like [M + H]+) or negatively charged analytes (like [M - H]-).
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In the case of large molecules, there are typically many charge states which are easily
detected.

Figure 2.4. An ionization mechanism: the charged residue model.

2.3.2. X-ray Photoelectron Spectroscopy. X-ray photoelectron spectroscopy
(XPS) is a surface analytical technique that non – destructively quantifies the elemental
composition at the surface of a material at the topmost 50 – 100 Å and to provides
chemical oxidation state information of the element examined (Hollander and Jolly,
1970).
2.3.2.1. Theory. When soft X-rays impinge onto the surface of a material being
analyzed, the electrons in various valence orbitals will be ejected via a photoelectric
effect. The kinetic energy of these emitted electrons are measured and recorded,
providing chemical information.
X-ray photoelectron spectroscopy provides qualitative and quantitative
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information about the surface of a material. Every elemental transition has its own
characteristic kinetic energy, which appear in the binding energy spectra recorded by
XPS. The binding energy range typically spans between 0 and 1250 eV. If a material
contains carbon, and oxygen elements, there will be signal peaks at around 285 eV (Barr,
1994), and 535 eV (Vaneica Y. Young and Kathryn R. Williams, 1999), respectively. The
percentage of each element can be quantified by examining their normalized integrated
peak areas.
Small shifts in the binding energy indicate a different oxidation state of this
particular element. Assuming that there are no final state effects, the chemical shift is
arises from the coordination between this element and other elements in the same
material. In Figure 2.5 (Siegbahn et al., 1967), the changes in the signal peak position are
indicated in the binding energy spectra due to changes in the oxidation state at C1s orbital
(Barr, 1994). In an electron deficient - environment, the binding energy increases; in an
electron – rich environment the binding energy decreases (Hagstrom et al., 1964).
2.3.2.2 Mechanism The emission of photoelectrons is initiated by the irradiation
of an X-ray with a certain known energy, hν (Figure 2.6). Assuming the 1s orbital of
element A, for example, has one photoelectron displaced by the X-ray beam, the reaction
occurring for element A would be:
A + hν

A+* + e

-

(7)

In this equation, A is a certain atom, hν is the energy of the X-ray beam, A+* is a
-

positively charged ion, and the electron, e , is the escaping electron from the 1s orbital of
atom A.
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The kinetic energy could be calculated by X-ray photoelectron spectroscopy using
the equation:
KE = hv – BE – Φ

(8)

KE stands for the kinetic energy of the emitted electron, hν for the energy of the
X-ray beam, BE for the binding energy of the electron from a particular orbital being
detected, and Φ for the work function of the spectrometer. The work function and the Xray energies remain constant when using the same instrument for measurement.
Therefore, the binding energy of this element could be determined by:
BE = hv – KE – Φ

(9)

2.3.2.3 Instrumentation A typical X-ray photoelectron spectroscopy system
consists of an X-ray source, a sample holder, an analyzer, a detector and a place for
detection within an ultra – high vacuum system (UHV) (Figure 2.7).
In the set – up used to acquire the data in this thesis, monochromatic soft X-rays
were produced by a Mg Kα anode (hν = 1253.6 eV). A sample holder was maintained at
a proper position in the ultra – high vacuum (UHV) for a suitable detection of electrons
by the spectrometer. UHV conditions were required to insure the flight of photoelectrons
into the detector analyzer and to reduce contamination on the material surface. The
pressure of this vacuum system was maintained between 10-8 Torr to 10-10 Torr before,
during and after analysis. The analyzer used for these experiments was a double-pass
cylindrical mirror analyzer with two spherical grids. Electrons were retarded using these
two grids to focus the photoelectrons into the detector. Usually two cylindrical mirror
analyzer are used together to increase the resolution in XPS systems.
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Figure 2.5. Carbon 1s X-ray photoelectron spectrum for ethyl trifluoroacetate.
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Figure 2.6. Mechanism of X-ray photoelectron spectroscopy.
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Figure 2.7. Schematic of X-ray photoelectron spectroscopy.
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3. MATERIALS AND METHODS

3.1. CHEMICALS
N-acetylcysteine amide was provided by Dr. Glenn Goldstein (David
Pharmaceuticals, New York, NY, USA). High-performance liquid chromatography
(HPLC) grade solvents and Na4EDTA were purchased from Fisher Scientific (Fair Lawn,
NJ). All other chemicals including N-acetylcysteine, were purchased from Sigma Aldrich (St. Louis, MO).

3.2. DETERMINAITON OF THE STOICHIOMETRY OF Pb - ANTIOXIDANT
COMPLEX
A stock solution of lead acetate and antioxidants of the same concentration were
prepared and maintained at a temperature between 0°C and 10°C. The volume ratio of
Pb(II) and antioxidants varied from 7:1 to 1:3 according to Job’s method (MacCarthy et
al., 1976). Job’s method is a quick and simple way to determine the stoichiometry of a
complex. When the volume ratio of two molecules is equal to their stoichiometric ratio,
the amount of the complex formed reveals a maximum. Figure 3.1 shows an example of
which the absorbance reaches to the maximum when the volume of the two reacting
molecules are at 1 to 1 ratio, so x, one molecule’s volume over the total volume, is equal
to 0.5. The stoichiometry is 1: 1. Each sample was tested under UV light, between
wavelengths of 300nm and 190nm which were then recorded.
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1:1

Figure 3.1. Determination of stoichiometry using Job’s method.

3.3.

STRUCTURE INFORMATION OBTAINED FROM ESI-MS
Lead acetate was dissolved with Na4EDTA, NAC, and NACA in doubly distilled

deionized water with a 1:1 ratio, respectively. The solutions containing Pb-antioxidant
complex were then analyzed by using a Thermo-Finnigan TSQ7000 triple-quadrupole
mass spectrometer. The heated inlet capillary was kept at 250°C and the electrospray
needle voltage was maintained at 4.5 kV. All voltages were chosen to maximize ion
transmission and minimize unwanted fragmentation.
DETECTION OF COORDINATED LEAD – THIOL GROUPS IN THE
ANTIOXIDANTS BY HPLC

3.4.

Sample solutions were prepared with Pb acetate and antioxidants at ratios of 0:1,
0.5:1, 1:1, 2:1 and 4:1. These solutions were introduced into high performance liquid
chromatography (HPLC). The HPLC system from Thermo Electron Corporation is
composed by a Finnigan Surveyor autosampler Plus, a Finnigan Surveyor LC pump Plus,
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and a Finnigan Surveyor fluorescence Plus detector (λex=330 nm, and λex=376 nm). The
HPLC column was a Reliasil C18 column (5 μm packing material) with 250×4.6 mm i.d.
(Orochem technologies INC. Lombard, IL, USA).
An isocratic program was used for Cysteamine hydrochloride testing. In this
program, mobile phase A was composed of a volume ratio of 70:30 acetonitrile and
HPLC- grade water, with 0.1% acetic acid and 0.1% o-phosphoric acid. The flow rate of
this program was 1.000 ml/min, the percentage of mobile phase A was 100%, and the
running time was 20 mins.
A gradient separation method was used for the detection of NAC and NACA (Wu
et al., 2006). Mobile phase A was composed of a volume ratio of 70:30 acetonitrileHPLC-H2O (v:v) with 0.05% acetic acid, and mobile phase B was composed of a volume
ratio of 70:30 acetonitrile-HPLC-H2O (v:v) with 0.04% o-phosphoric acid.
The running time for mobile phase A was from 0.1 min to 6.00 min, the flow rate
was 0.7 ml/min, and the volume was 100%. The running time for mobile phase B was
from 6.10 min to 10.00 min (Figure 3.2), the flow rate was 1.7 ml/min, and the volume
was 100% (Wu et al., 2006).
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Figure 3.2. A gradient method for NAC and NACA’s HPLC detection.

Stock solutions of the studied antioxidants were prepared by dissolving 6.5 mg
NAC (NACA: 6.5mg) in doubly distilled deionized water, making a concentration of
1mM. This 1mM concentration of NAC was then diluted to produce 100μM, 10μM, 1μM
and 0.1μM concentrations. Stock solutions of lead acetate were prepared by dissolving
15.2 mg Pb acetate trihydrate in doubly distilled, deionized water, making a 1 mM Pb(II)
solution. The 1 mM lead acetate was then diluted into 100 μM and 10 μM.
A calibration experiment was performed first to elucidate the relationship of the
peak area and the concentration, in which the concentrations varied: 2.5 nM, 12.5 nM, 25
nM, 50 nM and 125 nM. Table 1 details about the preparation of the standard solutions.
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Table 1. Calibration solution preparation for HPLC detection
Conc. (nM) Stock solution (μl) H2O (μl) NPM (μl) HCL (μl)
0

0

250

750

10

2.5

25.0 (0.1μM)

225.0

750

10

12.5

12.5 (1μM)

237.5

750

10

25

25.0 (1μM)

225.0

750

10

50

50.0 (1μM)

200.0

750

10

125

12.5 (10μM)

237.5

750

10

The experiment was divided into two parts, 0 hour and 1 hour time courses. For
the 0 hour experiment, sample solutions were quickly prepared from the stock solution
within 5 min; and then directly introduced to the autosampler system of the HPLC. Table
2 shows the components of sample solutions. In the case of the 1 hour experiment, a
stock solution was incubated in a 37 °C water bath for 1 hour, and then used to prepare
the remaining sample solutions. In all of the sample stock solutions, the concentration of
NAC was 1 μM, and the concentration of lead acetate varied: 0, 0.5 μM, 1 μM, 2 μM and
4 μM. These sample solutions were finally made into a 12.5 nM concentration solution.
Table 2. Sample solution for HPLC detection
Ratio of NAC :

Stock solution of NAC

Stock solution of Pb

H2O

(ml)

acetate (ml)

(ml)

1:0

5.00 (1 μM)

0

0

1 : 0.5

0.50(10 μM)

0.25 (10 μM)

4.25

1:1

0.50 (10 μM)

0.50 (10 μM)

4.00

1:2

0.50 (10 μM)

1.00 (10 μM)

3.50

1:4

0.50 (10 μM)

2.00 (10 μM)

2.50

Pb
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3.5.

DETECTION OF THE PERCENTAGE OF LEAD BEING CHELATED BY
USING XPS
X-ray photoelectron spectroscopy (XPS) was performed in an ion-pumped

Perkin-Elmer PHI 560 system using a PHI 25-270AR double-pass cylindrical mirror
analyzer. A magnesium Kα anode was operated at 15 kV and 250W with photon energy
of 1253.6 eV. The system pressure did not exceed 1x10–8 Torr during scans. The pass
energy used for high resolution XPS was 50 eV (0.1 eV/step and 90 ms/step). A 99.99%
purity Ta foil (Cross Co., Moonachie, NJ) was used as a metal support for the Pbantioxidant film. A 0.1 ml aliquot of Pb acetate-antioxidant, with a ratio of 5:1 solution
(lead acetate 2.5 mM : antioxidant 0.5 mM ) solution was loaded onto the 1cm x 1cm x
0.1 mm square surface, and then introduced into a turbopumped antechamber to
evaporate the liquid and outgas the sample prior to introduction into the UHV for XPS
analysis. The Ta substrate (spot-welded to electrical leads from the sample probe) was
cleaned by resistive heating by passing 12 amps through the Ta foil using a power supply
(Hewlard – Packard 6259B DC power supply). The surface was heated to 1200 K, which
sufficiently removed all of the Pb-antioxidant adsorbates. The C 1s level at 284.7 eV was
used for charge correction (Barr, 1994).

3.6.

POINT OF ZERO CHARGE VALUE DETERMINATION OF NAC AND
NACA
Solutions with pH values from 1 to 12 were prepared with HCl and NaOH

solutions with 0.3 ml aliquots of each pH solution added into 5 ml glass tubes containing
150 mg of NAC and NACA powder, respectively. The pH of each of the 12 tubes was
measured by a pH meter. After a16 hour incubation in a refrigerator, the final pH values
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of each tube was measured again and plotted to determine the point of zero charge values
(Park and Regalbuto, 1995).
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4. RESULTS

4.1.

SEVERAL COMPLEX FORMS
Structure information of a Pb-antioxidant complexes were obtained using UV -

vis spectrophotometry and ESI – mass spectroscopy. Job’s method was applied to
determine the stoichiometry of the Pb-antioxidant complex using a UV - vis
spectrophotometer. Figure 4.1.A shows the spectra for signals of a Pb-Na4EDTA
complex, indicating that 246 nm was the wavelength of maximum absorbance. According
to Job’s method, x was 0.5, indicating that the stoichiometry of this complex was 1:1
ratio. This result is consistent with the literature (Gupta et al., 2007). Figure 4.1.B depicts
the result for a Pb-NAC complex, also from Job’s method. From the spectra, the highest
absorbance of the signal was at 275 nm. The x was 0.286, so the stoichiometric ratio was
2.5:1for Pb:NAC. Figure 4.1.C reveals the spectra of a Pb-NACA complex. There were
the same as for the Pb-NAC complex, and 275 nm was the wavelength with the
maximum absorbance. The x was 0.4; therefore, the stoichiometric ratio was 1.5:1for PbNACA.
The stoichiometries of Pb-NAC and Pb-NACA were very different from each
other. The 2.5:1 ratio of Pb-NAC indicated that there was more than one single complex,
which was the case with Pb-NACA with its stoichiometry of 1.5:1.
Since there was more than one complex formed in Pb-NAC and Pb-NACA, it was
not possible to determine their binding constants by just using UV-vis spectroscopy. Job’s
method is only effective when only one complex formed in the solution, so an accurate
determination of the stoichiometry could not be made.
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A
B

B

C

Figure 4.1. Plot of Job’s method and spectra for a) Pb-EDTA complex; b) Pb-NAC
complex; and c) Pb-NACA complex.
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Electrospray ionization, coupled with mass spectrometry (ESI-MS), was applied
to detect the major complex in Pb-NAC and Pb-NACA complexes. Figure 4.2 shows the
signal of [Na3EDTA-Pb]+ at 565.09 m/z, a 1:1 ratio of Pb(II) : EDTA in the complex. This
result was consistent with the result obtained in the stoichiometry by using UV-vis
spectrophotometry. Figure 4.3 was the spectra of signal for the Pb(II) and NAC solution.
Pb(II) was able to coordinate with NAC by ratios of 1:1, 2:1, 2:2, and 3:2, resulting in a
signal for [Pb-NAC]+ at 369.77 m/z, a signal for [Pb-NAC-Pb-H2O]+ at 591.82 m/z, a
signal for [NAC-Pb-NAC-Pb]+ at 736.80 m/z, and a signal for [Pb-NAC-Pb-NAC-Pb]+ at
942.73 m/s. Their percentages of the total Pb-NAC complexes were 76.5%, 14.5%, 6.5%,
and 2.5%, respectively. These complexes all contribute to the multi-form of Pb-NAC.
Figure 4.4 reveals the spectra for the Pb acetate and NACA solution, in which case the
signal was not the same as for Pb-NAC. There were three major complex signals. One
was a signal [Pb-NACA-H]+ at 368.93 m/z. Two other peaks were observed at 529.08
m/z and 575.04 m/z for [Pb-(NACA-NACA)-H]+ and [Pb-NACA-Pb]+. Their
percentages of the composition were 92.2%, 4.8% and 3.0%, as shown in Table 3.
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Figure 4.2. Spectra of a derivatized Pb-EDTA from ESI-MS.

Figure 4.3. Spectra of a derivatized Pb-NAC from ESI-MS.
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Figure 4.4. Spectra of a derivatized Pb-NACA from ESI-MS.

Table 3. Composition of Pb-antioxidant complexes obtained from ESI-MS
Mass to charge ratio

Substance

% of the total Pb-

(m/z)

antioxidant substances

Na4EDTA

565.09

[Na3-EDTA-Pb]+

NAC

369.77

[Pb-NAC]+

NACA

100%
76.5%
+

591.82

[Pb-NAC-Pb-H2O]

14.5%

736.80

[NAC-Pb-NAC-Pb]+

6.5%

942.73

[Pb-NAC-Pb-NAC-Pb]+

2.5%

368.93

[Pb-NACA-H]+

92.2%

529.08

[Pb-(NACA-NACA)-H]

575.04

[Pb-NACA-Pb]+

+

4.8%
3.0%
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4.2.

CHELATING ABILITIES
Upon examination of the Pb-antioxidant complex forms and their relative

abundances, it was possible to estimate the chelating abilities of N-acetylcysteine amide
and N-acetylcysteine to lead divalent cation in vitro.
The chelating ability was evaluated by quantifying the percentage that Pb(II)
coordinated to the antioxidants. HPLC was applied to determine the amount of
antioxidants that had been coordinated. Cysteamine hydrochloride, NAC and NACA are
mono-thiol antioxidants that contain a sulfur-hydrogen functional group. By adding N(1-pyrenyl) maleimide (NPM) to the sample, the thiol group in the compounds
coordinated with NPM, formed a highly fluorescent complex for detection. A gradient
program was used for NAC and NACA in the HPLC system, so that the thiol group could
be both qualified and quantified. In the case of Cysteamine, an isocratic program was
applied. The retention times for NAC, NACA and Cysteamine were around 4.8 min, 5.2
min and 17.2 min, respectively. Figure 4.5 shows the declining trend of Cysteamine with
the increase of Pb acetate in a mixed solution. At a ratio of 1:1, there was a 19.0%
decrease in free Cysteamine concentration without any incubation, and a 33.5% decline
after 1 h incubation in a 37°C water-bath. Figure 4.6 also reveals a declining trend for
available NAC by using more Pb acetate. At a ratio of 1:1, 10.4% NAC reacted with
Pb(II) with no incubation, and 17.8% NAC with 1 h incubation in a 37°C water-bath. The
results were the same with NACA (Figure 4.7). With the addition of more Pb(II) acetate,
the decrease in free Cysteamine, NAC, and NACA was more obvious ( Table 4). In
addition, there was a great difference in the amount of reacted antioxidants between no
incubation and 1 hr incubation at 37°C temperature. There were more antioxidants being
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coordinated with lead acetate after 1 h of incubation, indicating a time period for a
reaction between the antioxidants and Pb(II).
Based on the amount of antioxidants that chelate Pb(II) and the percentage of the
major complex forms, the percentage of Pb(II) that had been reacted by NAC and NACA
could be estimated. In Pb-NAC, the major part is [Pb-NAC]+ with 76.5%. In this
complex, the ratio of Pb (II) to NAC was 1:1. From the results obtained from HPLC, the
total NAC reacted was 10.1% at a 1:1 ratio to the group with no incubation. Therefore,
the total amount of lead chelated in the complex [Pb-NAC]+ would be
76.5%×1×10.1%=7.7%. The total amount of Pb (II) being bound by NAC was estimated
by adding the percentage of lead reacted with all of the complex forms in the Pb-NAC
solution. The amount of Pb(II) complexed would be 11.7%. The percentage of lead
chelated by NACA was 21.8%.

Figure 4.5. Amount of Cysteamine available in the Pb(II) and Cysteamine solution.
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Figure 4.6. Amount of NAC available in the Pb(II) and NAC solution.

Figure 4.7. Amount of NACA available in the Pb(II) and NACA solution. (The filled bar
stands for 0h incubation result, and the blank bar for 1h incubation result at 37°C.)
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Table 4. Percentage of antioxidants that have been reacted with Pb(II)
1:0.5
0h

1:1
1h

0h

1:2
1h

0h

1:4
1h

0h

1h

NACA

25.5% 22.9% 21.7% 28.7% 25.4% 36.1% 29.7% 46.1%

NAC

7.8%

16.0% 10.1% 15.5% 12.0% 17.4% 12.5% 23.3%

Cysteamine 18.5% 29.1% 19.0% 33.5% 20.7% 24.1% 23.7% 34.8%

X-ray photoelectron spectroscopy was also applied to evaluate the chelating
abilities of antioxidants. The changes of binding energy at a Pb 4f orbital were observed
by analyzing the peaks, and comparing them to the control group (Figure 4.8). There
were two peaks at the Pb 4f orbital for the control group, due to the spin orbital coupling,
which only contained lead acetate; the two peaks were at 138.4eV and 143.3eV. In the
case of samples with Pb(II) dissolved with Na4EDTA, NAC and NACA separately, two
additional peaks were around 138.4eV and 143.3eV, apart from the control group (Figure
4.9, a graph for one Pb-NAC sample at a Pb 4f orbital). Therefore, four peaks of Pb 4f
were curve-fitted for the sample groups, deconvoluted using the analysis software,
CasaXPS VAMAS software version 2.2 (Devon, United Kingdom). The two additional
peaks, not observed in the control, signified the oxidation state in which Pb was bound to
the antioxidants.
The Pb 4f chemical oxidation states were quantified by measuring their XPS
integrated peak areas. The peaks of the control group at 138.4eV and 143.3eV were
denoted as components A and B in solid lines, and the two additional peaks that appeared
in the samples were components C and D in dot lines. The percentage of the area of
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component C, plus that of component D, over the areas of all of the peaks, is equal to the
percentage of Pb bound, as shown in the equation
Percentage of Pb(II) bound =

(10)

The sum of the percentage of component C and component D is shown in Table 5,
revealing the trend that NACA had a higher affinity with Pb (II), as compared to the
Na4EDTA and NAC groups (Figure 4.10). In all of the sample groups, 5mM Pb acetate
reacted with 1mM chelator/antioxidants. In the Na4EDTA group, 11.6% of Pb was bound,
and in the NAC sample, 10.3% of Pb was bound, while in NACA, 21.6% of the lead was
absorbed, twice the percentage of the Pb-Na4EDTA and Pb-NAC complexes.
There was only one functional group difference between NAC and NACA. Since
NACA is the amide form of NAC, it was anticipated that the two antioxidants would have
similar chelating abilities to Pb(II). However, NACA had a much higher affinity to Pb(II),
according to results from the XPS experiment. Thus, a study in determination of the point
of zero charge was carried out to understand the underlying reason for this difference.

4.3.

POINT OF ZERO CHARGE (PZC)VALUES
Figure 4.11 shows the initial and final pH values for both NAC and NACA. The

point of zero charge (PZC) for NAC was at pH=2.0, and for NACA, the pH was 5.1. The
pH value of the sample solution, in which Pb(II) dissolves with antioxidants, was at pH
4.6. From the perspective of surface chemistry, if a solid surface with a PZC is higher
than that of the surrounding aqueous solution, the surface will become protonated and
adopt a positive charge. Conversely, a solid surface with a PZC lower than that of the
surrounding solution is prone to be hydroxylated, adopting a negative surface charge.
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Clear difference in PZC between NAC and NACA were observed. NACA’s point
of zero charge value was higher than that of the sample solution, while NAC’s was lower
than that of the solution. We attribute the greater amenability of Pb(II) absoption to the
accumulation of positive charge on the NACA substrate.

Table 5. Percentage of Pb (II) that has been chelated by antioxidants

Component C % Component D %

C+D %

EDTA

5.8  1.4%

5.8  2.8%

11.6  2.6%

NAC

5.4  2.3%

5.3  1.3%

11.2  3.5%

NACA

10.5  2.7%

11.2  1.9%

21.6  0.9%

Figure 4.8. Control spectra for Pb 4f orbital.
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Figure 4.9. A sample spectra for Pb 4f orbital. This sample was composed of ratio 5:1 Pb
acetate and NAC in the solution.

Figure 4.10. Percentage of Pb(II) being chelated by Na4EDTA, NAC and NACA.
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Conditions for complex
formation (pH: 4.6)
solution

Figure 4.11. Point of zero charge values for NAC and NACA.
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5. DISCUSSION

Because of the harmful side effects of chelators, patients with low blood lead
levels are encouraged to leave areas prone to lead exposure. Only individuals who have
blood lead levels as high as 45 μg / dL or above, will be treated with chelation therapy.
The recent application of antioxidants provides a better treatment for lead poisoning,
because antioxidants are able to decrease the lead level, as well as relieve the oxidative
stress being induced.
N-acetylcysteine is the most popular drug among these antioxidants. This
antioxidant can be well absorbed by human bodies, and can cause a further decline in
blood lead levels. As a result, its amide form, N-acetylcysteine amide, is produced, which
might be better for decreasing lead levels. Therefore, it is necessary to compare the
chelating abilities of the two similar compounds in vitro.
Based on the Job’s method, it was possible to determine the stoichiometry of a
complex. However, this method was restricted to determining only one complex. The
data from UV-vis spectroscopy showed the consistency with literature of the Pb-EDTA
1:1 ratio stoichiometry, while the ratios of the Pb-NAC and Pb-NACA complexes were
2.5:1 and 1.5:1 ratio, respectively. The ratios of Pb-NAC and Pb-NACA indicated that
there were several complexes in the samples. As a result, it was not possible to determine
the exact stoichiometries for the Pb-NAC and Pb-NACA complexes, or their binding
constants, by using UV-vis spectroscopy.
To further understand the coordination between Pb and the antioxidants, the
molecular structures of Pb-NAC and Pb-NACA complexes were necessary. One of the
ways was to determine the direct coordination between lead and the antioxidants by
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making their crystals. Crystallization of the complexes had been unsuccessfully tried.
Although conditions of experiment were changed, such as the concentrations of lead
acetate and antioxidants in a solution, incubation temperature, time and solvent, there was
no crystal formation in the end. Another way to determine coordination was to use ESI
mass spectroscopy to detect the mass to charge ratio of a certain signal and to determine
whether there is a lead isotope peak. Since this ESI-MS system produces positron, every
signal peak stands for a compound with one positive charge. With the known molecular
weight of lead acetate, Na4EDTA, N-acetylcysteine and N-acetylcysteine amide, the
forms of the complexes were calculated and determined. From the results obtained, we
found four complex forms in the Pb-NAC sample, with ratios of 1:1, 2:1, 2:2 and 3:2.
Among them, the 1:1 ratio complex occupied the major part of the total complexes. In the
case of Pb-NACA, there were three complex forms with 1:1, 1:2 and 2:1 ratios. The PbNAC complex also had the 1:1 ratio form ass the major one, as in the Pb-NACA
complex. After understanding the complex forms for Pb-NAC and Pb-NACA, a
determination was made of the amount of lead chelated by the antioxidants, which
required combination of data from ESI-MS and HPLC. The results of the HPLC
experiment made it possible to estimate the percentage of antioxidants that had been
reacted. Thus, the amount of lead reacted could be interpreted based on the relative
abundance of the complex forms, and the ratios between the lead and NAC, NACA, and
the antioxidants reacted.
The use of X-ray photoelectron spectroscopy (XPS) allowed a quick, but efficient
estimate of the chelating abilities of different antioxidants. The percentage of Pb(II) could
be determined by using XPS, in which case it was not possible to know the composition
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of the multi-complexes and their relative percentages. The trend of chelating abilities
obtained from the XPS experiment was consistent with the combination results from the
ESI-MS and HPLC experiments, along with a comparison of their different point of zero
charge values. NACA was determined to be better than NAC in chelating Pb(II) in vitro.
The usual way to calculate the chelating ability of a compound is involved in knowing
the structure of a complex, as well as its reacted percentage. As a result, a wide range of
techniques, such ESI-MS, UV-vis spectrophotometer, HPLC and etc. are required to
detect the exact chelating ability of a complex. By using X-ray photoelectron
spectroscopy, it was more convenient and quick to assess the differentiated chelating
abilities among antioxidants. However, the data obtained from the XPS experiment is not
an absolute value, as it was not able to describe the exact chelating abilities of NAC and
NACA, because it is a semi-quantification method. Using XPS, it is only possible to
determine the percentage of lead reacted, but the amount of oxidation states of lead could
not be determined. Thus, this technique could only estimate the trend of chelating
abilities of the antioxidants. It is reasonable to assume that XPS is not a technique to be
used for quantification, since it can only roughly determine a value.
Future research can be concentrated on an in vivo experiment that involves animal
tests. An In vitro study comparing chelating abilities of NAC and NACA would be ideal
for evaluation their relative efficacies in lead poisoning treatment, validating the
predictive results in this study.
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APPENDIX A
Retention time for Cysteamine, NAC and NACA in HPLC Experiments

Cysteamine

Retention time for Cysteamine is at 17.2 minutes

NAC

Retention time for NAC is at 4.8 minutes
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NACA

Retention time for NACA is at 5.2 minutes
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